GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
52.51 -0.31  -0.59% NYSE Apr 17, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline Cash from Operations (TTM):

11.90B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Cash from Operations (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Operations (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 11.90B
Sept. 30, 2013 11.13B
June 30, 2013 7.298B
March 31, 2013 7.331B
Dec. 31, 2012 7.051B
Sept. 30, 2012 7.237B
June 30, 2012 10.26B
March 31, 2012 9.670B
Dec. 31, 2011 9.635B
Sept. 30, 2011 8.503B
June 30, 2011 7.796B
March 31, 2011 8.918B
Dec. 31, 2010 10.54B
Sept. 30, 2010 12.12B
June 30, 2010 13.19B
March 31, 2010 13.33B
Dec. 31, 2009 12.61B
Sept. 30, 2009 10.21B
June 30, 2009 9.890B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Operations

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More

Get data for
Advertisement

GSK Cash from Operations (TTM) Benchmarks

Companies
AstraZeneca 7.40B
Eli Lilly and 5.735B
Johnson & Johnson 17.41B

GSK Cash from Operations (TTM) Range, Past 5 Years

Minimum 7.051B Dec 2012
Maximum 13.33B Mar 2010
Average 9.927B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.